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SUMMARY 
 
 The syncytiotrophoblast (ST) is the major component of the human placenta, involved 
in feto-maternal exchanges and secretion of pregnancy-specific hormones. Multinucleated ST 
arises from fusion of mononuclear overexpression cytotrophoblast cells. In Trisomy 21- 
affected placentas, we recently have shown that there is a defect in ST formation and a 
decrease in the production of pregnancy-specific hormones. Due to the role of oxygen free 
radicals in trophoblast cell differentiation, we investigated the role of the key antioxidant 
enzyme copper/zinc superoxide dismutase (SOD-1), encoded by chromosome 21, in in vitro 
trophoblast differentiation. We first observed that over-expression of SOD-1 in normal 
cytotrophoblasts impaired ST formation. This was associated with a significant decrease in 
mRNA transcript levels and secretion of hCG and of other hormonal markers of ST. We 
confirmed abnormal cell fusion by overexpression of GFP-tagged SOD-1 in cytotrophoblasts. 
In addition, a significant decrease of syncytin transcript levels was observed in SOD-1 
transfected cells . We then examined SOD-1 expression and activity in isolated trophoblast 
cells from Trisomy 21- affected placentas. SOD-1 mRNA expression (p<0.05), protein levels 
(p<0.01), and activity (p<0.05) were significantly higher in trophoblast cells isolated from 
Trisomy 21-affected placentas than from normal placentas. These results suggest that SOD-1 
overexpression may directly impair trophoblast cell differentiation and fusion, and that of 
SOD-1 in Down's syndrome may be responsible, at least in part, for the failure of ST 
formation observed in Trisomy 21-affected placentas. 
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INTRODUCTION 
 In humans, fetal cytotrophoblasts play a key role in the embryo implantation process, 
and in placental development. In early pregnancy mononuclear cytotrophoblasts proliferate 
and invade the maternal endometrium to form the anchoring villi (1, 2). Cytotrophoblasts 
also fuse and differentiate into a continuous layer of multinucleated syncytiotrophoblast. 
This cell layer, which covers the chorionic villi, is bathed with maternal blood in the 
intervillous spaces from early gestation (3, 4). The syncytiotrophoblast layer plays a major 
role throughout pregnancy, since it is the site of numerous placental functions, including ion 
and nutrient exchange and the synthesis of steroid and peptide hormones required for fetal 
growth and development (5, 6). Some of these hormones, such as human chorionic 
gonadotropin (hCG), human placental lactogen (hPL) and placental growth hormone (PGH, 
also called growth hormone variant: GHV) are specific to pregnancy and can be used as 
markers of syncytium formation (7-9). 
 It has been established both in vivo and in vitro that the syncytiotrophoblast layer 
arises from the differentiation and fusion of mononuclear cytotrophoblasts. Isolated 
mononuclear cytotrophoblasts have been shown to aggregate and fuse together to form a non 
proliferative, multinucleated syncytiotrophoblast which synthesizes and secretes specific 
hormones required for fetal development (10, 11). This cytotrophoblast differentiation is 
stimulated in vitro by a number of factors, including EGF (12, 13), granulocyte stimulating 
factor (14), hCG (15, 16), glucocorticoids (17), and estradiol (18). Several studies also have 
shown that hypoxia inhibits cytotrophoblast differentiation and fusion (19-21). These results 
raise the interesting possibility that a change in cellular oxidative status may play a 
regulatory role in cytotrophoblast fusion and differentiation into syncytiotrophoblast. 
 Reactive oxygen species (ROS), including hydrogen peroxide (H2O2), superoxide ion 
(O2
.- ), and hydroxyl radical (.OH-) are generated in cells in response to stimulation by 
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various hormones, growth factors, and cytokines (22, 23). The oxygen radicals generated 
appear to act as second messengers in transmembrane signaling pathways to modulate 
cellular functions such as cell proliferation and differentiation (24, 25). Cellular oxidative 
status is determined by the balance between ROS production and their destruction by a 
variety of antioxidant enzymes. The primary antioxidant activity in the cell which regulates 
the level of O2
.- and its reactive progeny are the superoxide dismutases (SODs). Mammalian 
cells have a mitochondrial Mn-SOD, a cytoplasmic Cu, Zn-SOD which also is found in 
peroxysomes, and an extracellular SOD which is a Cu, Zn-SOD that is immunologically 
distinct from the classical Cu, Zn-SOD (26). These metalloenzymes act to dismute generated 
superoxide radicals to oxygen and H2O2 (23). In turn, catalase, along with peroxidases such 
as glutathione peroxidase, catalyse the decomposition of H2O2 to water and oxygen (27). 
 Both cytosolic Cu, Zn-SOD (SOD-1) and mitochondrial Mn-SOD are expressed in 
human cytotrophoblasts (28, 29). Extracellular Cu, Zn-SOD appears to localize within the 
villous extracellular matrix around the arterioles of the placenta (30). A role for SOD-1 in 
placental development has been suggested by results which show reduced fertility in 
transgenic female mice lacking SOD-1. In SOD-1 -/- female mice a post-implantation 
embryonic loss was observed with no placental development (31). Moreover, male SOD-1-
deficient drosophila are sterile, while SOD-1 deficient females exhibit markedly reduced 
fertility (32). However, little is known concerning a possible role for SOD-1 in human 
placental development. Recently, we demonstrated a modulation of SOD-1 expression and 
activity with in vitro differentiation of human villous cytotrophoblasts (33). Interestingly, we 
also have shown a failure of cytotrophoblast differentiation into syncytiotrophoblast in 
trisomy 21-affected placentas (34, 35). It has been known for sometime that SOD-1 is located 
on human chromosome 21, and that it is overexpressed in different trisomy 21-affected cell 
types (36). To better understand the role of SOD-1 in trophoblast differentiation, we have 
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employed an in vitro model of differentiation of human villous cytotrophoblast into 
syncytiotrophoblast to study the effect of overexpression of SOD-1 on the differentiation of 
these cells, and to determine the levels and activities of this enzyme in cytotrophoblast cells 
isolated from Trisomy 21-affected placentas which are unable to undergo normal 
differentiation and fusion to multinuclear syncytiotrophoblast. 
 
 
EXPERIMENTAL PROCEDURES 
 
Placental tissue collection. Term placentas were obtained after elective cesarean section 
from healthy mothers near term with uncomplicated pregnancies. French law allows 
termination of pregnancy with no gestational age limit when severe fetal abnormalities are 
observed. Samples of placental tissues were collected at the time of termination of pregnancy 
at 12-24 weeks of gestation (expressed in weeks of amenorrhea) in T21-affected pregnancies 
and gestational age-matched control cases. Gestational age was confirmed by ultrasound 
measurement of crown-rump length at 8-12 weeks of gestation. Fetal Down syndrome was 
diagnosed by karyotyping of amniotic fluid cells, chorionic villi or fetal blood cells. We 
checked that placental tissue was T21-affected by determination of DNA polymorphism 
markers (37). In no case was T21 due to translocation and no mosaicism was observed. 
Termination of pregnancy was performed in control cases affected by severe bilateral or low 
obstructive uropathy or major cardiac abnormalities. Fetal karyotype was normal in all 
controls. Placental samples were used for cytotrophoblast cell isolation or immediately frozen 
in liquid nitrogen. 
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RNA isolation and analysis. Total RNA was extracted from frozen placental samples by 
means of the single-step guanidinium-phenol-chloroform method described by Chomczynski 
and Sacchi (38) and from cultured cells following the procedure of Qiagen. Total RNA 
concentration was determined at 260 nm and its integrity was monitored by 1% agarose gel 
electrophoresis. Relative mRNA levels of the different genes were measured with the 
TaqMan5’ nuclease fluorogenic quantitative PCR assay essentially as previously described 
(39). The nucleotide sequences of the primers and probes are listed in table I. Each sample 
was analyzed in duplicate and a calibration curve was run in parallel for each analysis. The 
level of transcripts of the constitutive house keeping gene product cyclophilin A was 
quantitatively measured in each sample to control for sample-to-sample differences in RNA 
concentration and quality. The PCR data are thus reported as the number of transcripts per 
number of cyclophylin A molecules. 
 
Cell culture. Villous tissue was dissected free of membranes, rinsed and minced in Ca2+-, 
Mg2+-free Hank's balanced salt solution. Cytotrophoblast cells were isolated after trypsin-
DNase digestion and discontinuous Percoll gradient fractionation, using a slight modification 
of the method of Kliman and Alsat. (10, 11). The villous sample was submitted to sequential 
enzymatic digestions, in a solution which contains 0.5% of powder trypsin (W/V, Difco), 5 
IU/ml of DNAse I, 25 mM HEPES, 4.2 mM MgSO4 and 1% (W/V) penicillin/streptomycin 
(Biochemical industrie) in HBSS and monitored under light microscopy. The first and/or 
second digestion were discarded after light microscopy analysis in order to eliminate 
syncytiotrophoblast fragments and the following four or five sequential digestions are kept. 
The cells collected during these last digestions were purified on a discontinuous gradient of 
percoll (5 to 70% in 5% step). The cells which have migrated in the middle layer (density 
1.048-1.062 g/ml) were plated on culture dishes (106 cells/cm2), attached to the dishes and 3 
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hours after plating they were carefully washed by three efficient washes with culture medium. 
Following this procedure, we have determinated that at 3 hours of culture, 95% of the cells 
isolated from normal or T21 placentas were cytokeratin 7-positive using a specific 
monoclonal antibody (dilution 1:200, Dako), less than 0.5% were vimentin-positive (dilution 
1:200, Amersham International) and the other cells were mononucleated cells and identifed as 
macrophages. None of these cells were hPL-positive using a polyclonal specific antibody 
(dilution 1:500, Dako). Cells were plated in triplicate either on glass slides for 
immunocytochemistry studies or onto 60 mm culture dishes (106 cells/cm2). They were 
cultured for 3 days as previously described (11). 
 
Cell staining. To detect desmoplakin or E-cadherin, cultured cells were rinsed with PBS, 
fixed, and permeabilized in methanol at -20 °C, for 25 min. A monoclonal antidesmoplakin or 
E-cadherin antibody (1:400, Sigma) was then applied, followed by fluorescein isothiocyanate-
labeled goat anti-mouse immunoglobulin (Sigma), as previously described (19). 
 
Immunoblotting. To detect hPL, cell extracts were prepared as previously described (19) and 
solubilized protein (5 µg) was immunoblotted using a rabbit polyclonal antibody against hPL 
(1:250, Dako) and the specific band was revealed by chemiluminescence (Pierce supersignal, 
Interchim) after incubation with an anti-rabbit peroxidase-coupled antibody (19). To detect 
SOD-1, cell extracts were prepared as previously described (19) and solubilized protein (5 
µg) was immunoblotted using a sheep polyclonal antibody against human SOD-1 (The 
binding Site Limited). The specific band was revealed by chemiluminescence (Pierce 
Supersignal) after incubation with an anti-sheep peroxidase-coupled antibody. 
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Hormone assay. hCG concentration was determined in culture media using the 
chemiluminescent immunoassay analyser ACS-180SE system (Bayer Diagnostics). Assay 
sensitivity was 2 mU/ml. hPL concentration was assayed (Amerlex IRMA, Amersham) in 
four-fold concentrated conditioned media. Assay sensitivity was 0.5 µg/ml. All values are 
means ± SEM of triplicate determinations. 
 
Cu/Zn Superoxide dismutase (SOD-1) activity. Cultured trophoblast cells were washed 3 
times with ice-cold phosphate buffered saline and harvested by scraping into ice-cold buffer 
(0.25 M sucrose, 20 mM Tris pH 7.4, 1 mM MgCl2) with a cell scraper. Cells were pelleted 
by centrifugation at 1000 g for 5 min and then frozen at -80°C. Cell pellets were disrupted by 
sonication in 100 µl of 10 mM sodium phosphate buffer, pH 7. SOD-1 activity was measured 
as previously described (40). Briefly, xanthine-xanthine oxidase was utilized to generate an 
O2.- flux and the reduction of 2-(4-iodophenyl)-3-(4-nitrophenol)-5-phenyltetrazolium 
chloride (INT) to red formazan by O2.- was monitored at 505 nm at 30°C. The rate of INT 
reduction in the absence of samples was used as the reference rate (0.02 ± 0.005 
absorbance/min). Each assay tube contained 1 mM EDTA, 25 µM INT, 50 µM xanthine, 1 
U/ml catalase and enough xanthine oxidase to insure 100% non-inhibition, plus 50 mM (3-
[cyclohexylamino]-1-propane-sulfonic acid) (CAPS) buffer, pH 10.2. All data were expressed 
in units of SOD activity per mg of protein. 
 
DNA transfection. Cytotrophoblasts were isolated from placentas after elective cesarean 
section in healthy mothers with uncomplicated pregnancies at term. Transfection of 
cytotrophoblast primary cultures was performed by lipofection using the TransFast 
Transfection Reagent (Promega), according to a protocol adapted from Jacquemin’s method 
(41). The transfection efficiency is 10±3% as measured by β−galactosidase assay. Briefly, 2.5 
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µg of pRSV-SOD-1 cloned from human syncytiotrophoblast mRNA (Pharos), or empty 
vector, was mixed with TransFast Reagent in a 1:1 lipid:DNA ratio. After 15-min incubation 
at room temperature, 2 ml of the TransFast Reagent/DNA mixture were added to each plate 
(60 mm), and the cells were immediately placed in the incubator for 1 hour. Cells were then 
overlaid with 4 ml of complete medium and returned to the incubator for 24 hours. The 
medium was sampled every day for 3 days to determine hCG levels. At 72 hours, the cells 
were harvested by scraping in the presence of 10 mM phosphate buffer and protein 
concentration was determined using bovine serum albumin as standard. SOD-1 mRNA and 
SOD-1 activity were assayed to assess transfection efficiency. Transfections were performed 
in triplicate with 3 different primary cell cultures and 2 different DNA preparations. 
 
Construction of the SOD-1-GFP expression plasmid. An SOD-1-GFP gene fusion was 
created by amplifying a DNA product carrying the human SOD-1 gene from plasmid, 
pRSVSOD-1 by polymerase chain reaction. The forward (5'-GCCGATCTCGAGATGGCGA 
CGAAGGCCGTGTGC-3') and reverse (5'-GACCGGCCGCGGGGCGATCCCAATTACAC 
CACAAG-3') primers used to amplify SOD-1 incorporated XhoI and SacII restriction sites 5' 
and 3' to the gene, respectively. These sites were used to insert the gene into identical site 
within the plasmids pEGFP-N1 and pEGFP-C3 (Clonetech laboratories, Inc.). This created 
inframe fusions with the GFP coding region at the C-terminus (pEGFP-N1) or N-terminus 
(pEGFP-C3) of SOD-1. 
 
Protein determination. Protein was determined according to Bradford’s method (BioRad) 
using bovine serum albumin as standard. 
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Statistical tests. Statistical analysis was performed using the StatView F-4.5 software 
package (Abacus Concepts, Inc.). Values are presented as mean ± SEM. Significant 
differences were identified using Mann-Whitney analysis for hormonal secretions and 
ANOVA for transfections; p < 0.05 was considered significant. 
 
 
RESULTS 
 
Effect of Cu/Zn SOD-1 overexpression in normal cytotrophoblasts. 
As shown previously, purified mononuclear cytotrophoblasts isolated from normal 
human term placenta aggregate, fuse and form a large multinucleated syncytiotrophoblast 72 
hours after plating in culture (10, 11). This in vitro syncytiotrophoblast formation is 
associated with significant increases in hCGα mRNA, hCGβ mRNA, hPL mRNA, leptin and 
PGH mRNA levels (34). Concomitantly, hCG, hPL and leptin levels were shown to increase 
with time in conditioned media of the differentiated syncytiotrophoblast (34). 
To determine the effect of SOD-1 overexpression on cytotrophoblast differentiation and 
fusion into syncytiotrophoblast, we transiently transfected isolated cytotrophoblasts with 
SOD-1. The purity of cytotrophoblast cell population was firstly checked by cytokeratin 7 
immunostaining (Fig.1A) before transfection. As shown in Fig. 1B, in SOD-1 transfected 
cells, both SOD-1 mRNA and SOD-1 enzymatic activity were found to be elevated. After 
transfection of these primary cultures, SOD-1 mRNA levels were increased about 5 fold while 
SOD-1 activity was increased by approximately 30%. No increase in SOD-1 mRNA or SOD-
1 activity was detected in control cells transfected with the empty vector. Western blot 
analysis showed that SOD-1 protein levels also were significally higher (45% and p≤ 0.001) 
in transfected cells relative to control cells transfected with the empty vector (Fig.1C). 
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With differentiation and fusion of cytotrophoblasts into syncytiotrophoblast, there is an 
increase in the mRNA transcript levels of the placental hormones, hCGα, hCGβ, hPL and 
placental GH. The appearance of these hormones can be used as markers of syncytium 
formation. As shown in Fig.2A, the mRNA levels of these marker hormones were 
significantly decreased in cells overexpressing SOD-1 compared to control cells transfected 
by the empty vector. Further, the overexpression of SOD-1 in normal cytotrophoblasts also 
resulted in a significant (p≤ 0.0001) decrease in hCG secretion compared to control cells 
transfected by the empty vector (Fig.2B). In other studies, hPL production could be detected 
in the culture medium of SOD-1 transfected cells (data not shown). 
A recent study has shown that a retroviral envelope glycoprotein HERV-W, also called 
syncytin is directly implicated in the trophoblastic fusion process (42). Indeed, the expression 
of recombinant syncytin in a variety of cell types was shown to induce the formation of giant 
syncytia. Further, the fusion of a human trophoblastic cell line expressing endogenous 
syncytin was found to be inhibited by an anti-syncytin antiserum. These data indicate that 
syncytin may mediate placental cytotrophoblast fusion. Thus, we determinated the expression 
of syncytin mRNA in cytotrophoblasts by real-time quantitative RT-PCR (Fig.3). First, we 
confirmed with our primary culture of human cytotrophoblast model that there is a significant 
increase (p≤ 0.0002) in syncytin mRNA levels during the cytotrophoblast differentiation and 
fusion (Fig.3A). In SOD-1 transfected cells, syncytin mRNA expression was found to be 
decreased compared to control cells transfected with the empty vector (Fig.3B). 
 
Overexpression of GFP-tagged SOD-1 in normal cytotrophoblasts inhibits cell fusion. 
To further demonstrate that overexpression of SOD-1 may be implicated in the failure 
of cytotrophoblasts to fuse and differentiate, PCR products of SOD-1 were produced and then 
cloned into the pEGFP-N1 vector as described in materials and methods. This expression 
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vector then was used to transfect normal human cytotrophoblasts to overexpress GFP-tagged 
SOD-1. Cells overexpressing GFP-SOD-1 can be recognized within the cell population by the 
presence of green fluorescence due to the presence of the GFP tag. It was observed that 
cytotrophoblasts overexpressing GFP-tagged SOD-1 remained mononucleated and 
aggregated, as visualized by the detection of desmoplakin (Fig.4). In contrast, cells on the 
same dish which were not overexpressing GFP-SOD-1 (absence of green fluorescence) fused 
to a multinucleated syncytium. Similar results were obtained using expression vectors 
containing GFP fused to either the C-terminus or N-terminus of SOD-1 (data not shown). 
Moreover, the GFP-tagged SOD-1 fusion protein was shown to retain catalytic activity, as 
determinated by assay of increased SOD-1 activity (data not shown). 
 
SOD-1 mRNA and protein levels in normal and Trisomy 21-affected placentas. 
We recently observed that villous cytotrophoblasts isolated from Trisomy 21- affected 
placentas either do not, or poorly, differentiate and fuse into multinucleated 
syncytiotrophoblast (34). Due to the known location of the human SOD-1 gene on 
chromosome 21 (43), we measured the SOD-1 mRNA and protein levels in total tissue 
extracts prepared from 5 normal and 7 trisomy 21-affected placentas matched for gestational 
age. Figure 5, panel A, shows SOD-1 mRNA levels in these total tissue extracts, normalized 
to pleiotropin (PO), cyclophilin A (PPIA), and cytokeratin 7 (KRT7) mRNA expression as 
reference markers. No significant difference in SOD-1 mRNA transcript levels was found 
between Trisomy 21 affected and normal total tissue extracts, regardless of the reference gene 
used. Western blotting (Fig.5B) showed no difference in SOD-1 protein levels between the 
normal and abnormal tissues. These results were consistent with the similar SOD-1 mRNA 
levels in normal and Trisomy 21-affected placentas. 
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SOD-1 mRNA and protein levels in trophoblast cells isolated from normal and Trisomy 
21-affected placentas. 
Since cytotrophoblasts constitute a small percentage of the heterogeneous cell 
population found in placentas, we wanted to determine directly if SOD-1 might be increased 
in isolated population of T21 cytotrophoblasts. Thus, cytotrophoblast cells were purified and 
isolated from gestational age-matched normal and Trisomy 21-affected placentas as described 
in Methods. As shown in Figure 6 (panel A), SOD-1 mRNA was found in T21 trophoblast 
cells at a level about 1.5 times higher than in normal trophoblast cells. This increase in SOD-1 
mRNA expression was statistically significant (p<0.05) and highly reproducible. SOD-1 
protein levels and catalytic activity also were determined in both normal and Trisomy 21-
affected trophoblast cells (panels B and C). Again, the SOD-1 protein levels (p<0.01) and 
enzymatic activity (p<0.05) were significantly higher in Trisomy 21 cells than in normal 
trophoblast cells, in keeping with the observed elevation of mRNA levels found in T21 
cytotrophoblasts. These results establish and confirm that cells of individuals with this genetic 
disease, including cytotrophoblasts, have elevated levels of SOD-1 protein and catalytic 
activity. Further these cytotrophoblasts isolated from Trisomy 21-affected placenta poorly 
differentiate into syncytiotrophoblasts. 
 
 
DISCUSSION 
 
 Few human cell types can fuse together and differentiate into multinucleated syncytia. 
This process is involved in the formation of myotubes (44), osteoclasts (45) and 
syncytiotrophoblast (3). The syncytiotrophoblast is the primary site of several placental 
functions, including nutrient exchanges, metabolism and steroid and peptide hormone 
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synthesis, which are required for fetal growth and development (5, 6, 46). Despite a common 
morphological differentiation process, the three cell types which are able to differentiate into 
a syncytium differ notably. Syncytiotrophoblast in situ maintains a strong polarity, with 
microvilli on the apical membrane, while myotubes do not exhibit morphological polarity. 
The myoblast-myotube transition first requires the withdrawal of myoblasts from the cell 
cycle to G0, while cytotrophoblasts which fuse to create the syncytiotrophoblast already are 
essentially in G0 (10). In contrast to syncytiotrophoblast, osteoclasts have major locomotor 
activity. 
 The cell-cell fusion process involved in syncytiotrophoblast formation is poorly 
understood (47). In vitro studies have established that soluble factors such as EGF (12), 
parathyroid hormone (11) and hCG (15) activate different intracellular signaling pathways to 
stimulate the differentiation of villous cytotrophoblasts into syncytiotrophoblast. The cellular 
processes leading to syncytial formation are associated with a concomitant increase in the 
intracellular level of cyclic AMP (48) (49). This elevation in cyclic AMP levels is required for 
synthesis of numerous specific trophoblast proteins and hormones (see for review (50). We 
also have reported a direct role for cyclic AMP dependent protein kinases in simulating 
cytotrophoblast fusion (51). On the other hand, we and others have observed that 
cytotrophoblast fusion and differentiation is inhibited by hypoxia (19-21). Similarly the 
histological abnormalities of term placentas in pregnancy associated with underperfusion and 
hypoxia are characterized by cytotrophoblast prominence and abnormalities in 
syncytiotrophoblast differentiation (52, 53). This suggests that the oxidative state of the 
cytotrophoblast may be a key element in regulating differentiation into syncytium, and points 
to a direct role for oxygen derived free radicals in the modulation of cell fusion.  
 Cu/Zn superoxide dismutase (SOD-1) is a cytoplasmic enzyme which protects cells 
from oxygen-derived free radicals (26). SOD-1 transforms the superoxide anion O2
.- into 
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hydrogen peroxide, which is then converted to water by peroxisomal catalase and glutathione 
peroxidase (GPx). This two-step process eliminates H2O2 and other reactive oxygen species 
that could otherwise interact with macromolecules such as DNA, proteins and lipids, to alter 
their structure and function. However, any alteration of the balance between the first and 
second step may induce an oxydative stress related to the misregulation of H2O2 production. 
 The SOD-1 gene is located on human chromosome 21 (43). The activity of this enzyme 
is increased by about 50% in the red blood cells (54), platelets (55), lymphocytes, 
polymorphonuclear granulocytes and fibroblasts (56) of individuals with Down’s syndrome 
(Trisomy 21). In this study, we first established that SOD-1 mRNA, protein and activity were 
present in isolated normal human trophoblast cells, confirming and extending previous 
reports, based on RT-PCR, differential display and immunostaining (12, 28, 57). It then was 
shown that SOD-1 expression and activity in purified trophoblast cells isolated from Trisomy 
21-affected placentas were about 50% higher than in normal trophoblasts, in keeping with a 
gene dosage effect. This increase in SOD-1 activity in cytotrophoblasts isolated from 
Trisomy 21-affected placenta is associated with a defect of fusion and syncytiotrophoblast 
formation. These in vitro data are in agreement with recent data reporting histomorphological 
features of chorionic villi in Trisomy 21-affected pregnancies, showing increased double 
layer proliferative trophoblasts (58). This suggests that overexpression of SOD-1 leads to 
increased oxidative stress and trophoblast injury tending to stimulate proliferation and to 
decrease differentiation as observed in other pathological conditions. 
 However, when SOD-1 expression was compared in total tissue extracts from Trisomy 
21-affected placentas and normal controls matched for gestational age, no significant 
differences was found in SOD-1 transcript or protein levels. This finding appears to be due to 
the heterogeneous composition of the whole placenta. Total placenta extracts contain material 
of fetal origin, including fibroblasts, endothelial cells, and trophoblast cells. It also contains 
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material of maternal origin, including red blood cells, along with endothelial and decidual 
cells; Therefore, SOD-1 levels in total placental extracts reflect the SOD-1 expression in 
various cells of both fetal and maternal origin. SOD-1 is known to be highly expressed in 
maternal red blood cells and decidual cells (59). Since cytotrophblasts make up only a small 
percentage of the heterogeneous cell population found in placentas, we were unable to detect 
an elevation in SOD-1 levels in total tissue extract from the Trisomy 21-affected placentas. 
 In this study, experimental evidence suggests that an alteration in the oxydative state of 
human trophoblast cells related to overexpression of SOD-1 appears to be associated with a 
failure of differentiation and fusion into syncytiotrophoblast. This was illustrated by the 
inability of cells overexpressing SOD-1 to undergo cell-cell fusion. Indeed, we observed that 
primary normal human trophoblasts overexpressing SOD-1 tagged with green fluorescent 
protein remained mononucleated and aggregated, as visualised by the detection of 
desmoplakin. In contrast, cells on the same dish which did not expressed SOD-1-GFP were 
able to fuse to a multinucleated syncytium. The inability of cells overexpressing SOD-1 to 
fuse and differentiate into syncytiotrophoblast was associated with a significant decrease in 
the transcipt levels of genes encoding for pregnancy specific hormones such as hCG, hPL and 
placental growth hormone. These hormones are specifically expressed only by the 
differentiated syncytiotrophoblast. It should be noticed that this significant decrease in 
syncytiotrophoblast hormonal markers expression was in contrast with the relatively low 
transfection efficiency of these primary trophoblast cultures. Therefore it can not be excluded 
that by cell-cell interaction or paracrine effects, one transfected cell may affect different non 
transfected neibourhing cells.  Indeed, modulation of the oxidative status of one trophoblast 
cell overexpressing SOD-1, may induce for exemple cytokine secretions involved in 
trophoblast differentiation.  
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 Other evidence has suggested that endogenous retroviral gene expression also may be 
involved in the mediating cell fusion. Indeed, high expression of retrovirus is one of the 
characteristic of human syncytiotrophoblast (60, 61). This observation of retroviral particles 
in placenta, along with the presence of fused placental cells morphologically reminiscent of 
virally-induced syncytia, led to the proposal that an ancient retroviral infection may have 
been a pivotal event in mammalian evolution (61). Recently, syncytin gene expression, which 
codes for a retroviral envelop protein, was shown to be increased, and required for 
trophoblastic cell fusion (42). In this communication, we confirmed by real-time PCR that the 
transcript levels of syncytin increased with the differentiation and fusion of cytotrophoblasts 
into syncytiotrophoblast. Further, it was shown that impaired cell fusion related to 
overexpression of SOD-1 was associated with a decrease in the transcript level of syncytin. 
 Individuals with Down’s syndrome appear to exhibit increased oxidative stress (62, 63). 
They develop Alzheimer-like neuronal changes by the third or fourth decade of life, the 
incidence of autoimmune diseases and cataracts is significantly increased (64), and the overall 
aging process is accelerated (65). In addition, evidence that SOD-1 may be involved in the 
pathophysiology of Down’s syndrome includes the demonstration that SOD-1 gene 
overexpression can impair neurotransmitter transport and alter neuromuscular junctions (66, 
67). Here evidence is presented which indicates that elevated SOD-1 levels may play a 
critical role in modulating the cell differentiation, especially the cell-cell fusion, process 
involved in human syncytiotrophoblast formation. Results presented in this communication 
also clearly demonstrate a relationship between elevated SOD-1 levels in human 
cytotrophoblasts and the decreased production of pregnancy-specific hormones found with 
differentiation to syncytiotrophoblast. Taken together, the results presented here suggest that 
the elevated level of SOD-1 noted in Trisomy 21 may be responsible, at least in part, for the 
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failure of cytotrophoblasts to fuse and from multinucleated syncytiotrophoblast as noted in 
Down syndrome (34, 35). 
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FIGURE LEGENDS 
 
Figure 1: Characterization of SOD-1 overexpression in normal cytotrophoblast cells. 
Panel A: Cytokeratin 7 immunodetection after 24 hours of culture of trophoblast cells 
isolated from normal placenta. Positive immunofluorescence staining is specific of 
cytotrophoblast cells. 
Panel B: Transfection experiments. Cytotrophoblast cells isolated from normal placenta were 
transfected with an empty plasmid used as control (Control), or with a SOD-1 expression 
vector (SOD-1). Data are expressed as levels of SOD-1 mRNA normalized by PPIA mRNA 
(Peptidylprolyl isomerase A, cyclophilin A). SOD-1 activity in these cells is expressed as 
IU/mg of protein. The results presented are expressed as the mean ± SEM of 3 culture dishes. 
Panel C: SOD-1 protein levels after transfection were determined by western blotting with a 
sheep polyclonal antibody to SOD-1. The autoradiogram (upper panel) shows a specific band 
of 17 kDa in normal cytotrophoblasts transfected either with an empty plasmid (Control, 3 
separate dishes), or with a SOD-1 expression vector (SOD-1, 3 separate dishes). The lower 
histogram represents densitometry quantification of the autoradiograms (mean ± SEM of 3 
culture dishes).  
The figure represents one of three experiments. ***: p≤0.001. 
 
Figure 2: SOD-1 overexpression in normal cytotrophoblasts inhibits the increase in placenta 
hormone production noted with differentiation. 
Panel A: hCGα, hCGβ, PGH, hPL and leptin mRNA levels determined, by quantitaitve real- 
time PCR, in normal cytotrophoblasts transfected either with an empty plasmid used as 
control (Control), or with a SOD-1 expression vector (SOD-1). These assays were carried out 
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72h after plating. Values are the levels of each hormonal mRNA normalized to the level of 
PPIA mRNA. 
Panel B: levels of hCG secreted into the culture medium 72 hours after transfection 
determined by chemiluminescent immunoassay. Normal cytotrophoblasts were tranfected 
either with an empty plasmid used as control (Control), or with a SOD-1 expression vector 
(SOD-1). Data are the mean values for 3 separate dishes ± SEM.  
The figure illustrates one representative experiment of  3 performed. *: p≤0.05; ***: p≤0.001. 
 
Figure 3: SOD-1 overexpression in normal cytotrophoblasts blocks the increase of syncytin 
mRNA expression noted with differentiation. 
Panel A: Syncytin mRNA levels are mesured by real-time quantitative RT-PCR during 
normal cytotrophoblast differentiation and fusion. 
Panel B: Syncytin mRNA levels were measured by real-time quantitative RT-PCR in normal 
cytotrophoblasts after transfection either with an empty plasmid (Control), or with a SOD-1 
expression vector (SOD-1). Syncytin mRNA levels are normalized to PPIA mRNA levels 
(mean ± SEM); ***: p≤0.001. These assays were carried out 72h after plating. 
 
Figure 4: Overexpression of GFP-SOD-1 protein in normal cytotrophoblasts inhibits cell 
fusion. 
Cells overexpressing GFP-SOD-1 can be detected by the appearence of green fluorescence. 
The cells expressing GFP-SOD-1 remain aggregated and do not fuse, as determinated by the 
presence of desmoplakine (red fluorescence). In the same dish, cells which are not expressing 
the GFP-SOD-1 chimera protein were able to differentiate and fuse to a multinucleated 
syncytium as determinated by the absence of desmoplakine. Nuclei were labelled with DAPI 
(blue fluorescence). 
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Figure 5: SOD-1 mRNA and protein expression in total tissue samples obtained from normal 
(N) and Trisomy 21-affected placentas (T21). 
Panel A: SOD-1 mRNA levels determined, by real-time quantitative PCR are normalized to 
PO, PPIA and KRT7 mRNA levels (mean ± SEM). SOD-1 mRNA levels were determined in 
5 normal placentas and 7 Trisomy 21-affected placentas. 
Panel B: SOD-1 protein levels determined by western blotting with a sheep polyclonal 
antibody to SOD-1. This autoradiogram shows a specific band of 17 kDa in normal (N) and 
Trisomy 21-affected placentas (T21). The lower histogram represents densitometry 
quantification of the autoradiograms (N: n=5; T21: n=7). 
 
Figure 6: SOD-1 mRNA and protein levels, and catalytic activity, in purified trophoblasts 
prepared from normal (N) and Trisomy 21-affected placentas (T21). 
Panel A: SOD-1 mRNA levels determined, by real-time quantitative PCR, are normalized to 
PPIA mRNA levels (mean ± SEM). SOD-1 mRNA levels were determined in isolated 
trophoblasts prepared from 5 normal and 7 Trisomy 21-affected placentas. *: p≤0.05 
Panel B: Human SOD-1 protein levels determined by western blotting with a sheep 
polyclonal antibody to SOD-1. The autoradiogram shows a specific band at 17 Kda in 
trophoblasts isolated from normal (N) and Trisomy 21-affected placentas (T21). The 
histogram represents densitometric quantification of the autoradiograms (N: n=5; T21: n=7). 
Panel C: Human SOD-1 activity is expressed in IU/mg protein. The results are expressed as 
means ± SEM. *: p≤0.05; **: p≤0.01. 
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genes primers and probes GenBankaccession number proteins
CGA
(+) TCCCACTCCACTAAGGTCCAA
(-) CCCCATTACTGTGACCCTGTT
FAM-CACAGCAAGTGGACTCTGAGGTGACG-TAMRA
106 bp V00518 hCGa
CGB
(+) GCTACTGCCCCACCATGACC
(-) ATGGACTCGAAGCGCACATC
FAM-CCTGCCTCAGGTGGTGTGCAACTACC-TAMRA
94 bp J00117 hCGb
CSA
(+) GCATGACTCCCAGACCTCCTT
(-) TGCGGAGCAGCTCTAGATTGG
FAM-TTTCTGTTGCGTTTCCTCCATGTTGG-TAMRA
157 bp J03071 hPL
GHV
(+) AGAACCCCCAGACCTCCCT
(-) TGCGGAGCAGCTCTAGGTTAG
FAM-TTTCTGCTGCGTTTTCACCCTGTTG-TAMRA
96 bp J03071 PGH
LEPTIN
(+) ACATTTCACACACGCAGTCAGT
(-) CCATCTTGGATAAGGTCAGGAT
FAM-TGGAGCCCAGGAATGAAGTCCAAA-TAMRA
96 bp U18915 leptin
KRT7
(+) GGACATCGAGATCGCCACCT
(-) ACCGCCACTGCTACTGCCA
FAM-TCACGGCTCCCACTCCATCTC-TAMRA
171 bp X03212 cytokeratin 7
PTN
(+) GAGATGTAAGATCCCCTGCAACT
(-) CTCGCTTCAGACTTCCAGTTCT
FAM-AGCAATTTGGCGCGGAGTGCAA-TAMRA
125 bp M57399 pleiotropin
PPIA
(+) GTCAACCCCACCGTGTTCTT
(-) CTGCTGTCTTTGGGACCTTGT
FAM-AGCTCAAAGGAGACGCGGCCCA-TAMRA
97 bp Y00052 cyclophilin A
HERV-W (+) CGGACATCCAAAGTGATACATCCT
(-) TGATGTATCCAAGACTCCACTCCA
100 bp / syncytin
SOD-1
(+) CTGAAGGCCTGCATGGATTC
(-) CCAAGTCTCCAACATGCCTCTC
 FAM- TCATCCTTTGGCCCACCGTGTTT -TAMRA
138 pb X02317
CuZn superoxide
dismutase
Table 1: Characteristics of the PCR assays used in this study.
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